Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
09/2005
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
09/14/2005CN1668615A Novel benzimidazole derivatives
09/14/2005CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/14/2005CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors
09/14/2005CN1668300A Spirocyclic piperidines as MCH1 antagonists and uses thereof
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1667126A Alpha-thiomethyl-diketopiperazine A4 and preparation method thereof
09/14/2005CN1218948C Process for separating and preparing samguinarine and chelerythrine
09/13/2005US6943259 Halogenated triptolide derivatives as immunomodulators and anticancer agents
09/13/2005US6943199 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders
09/13/2005US6943186 Administering benzopyrazolyl compound for therapy of sepsis
09/13/2005CA2358724C New cyclobutene-dione derivatives, their method of preparation and pharmaceutical compositions containing them
09/13/2005CA2216099C Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/09/2005WO2005082920A1 Crystalline forms of a pharmaceutical compound
09/09/2005WO2005082909A1 Glucocorticoid receptor modulator compounds and methods- utility
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082883A2 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
09/09/2005WO2005082852A1 Weakly basic hindered amines having carbonate skeletons, synthetic resin compositions, and coating compositions
09/09/2005WO2005082841A1 Immunosuppressant compounds and compositions
09/09/2005WO2005062985A3 Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
09/09/2005WO2005044192A3 Triazole compounds and uses related thereto
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2557278A1 Glucocorticoid receptor modulator compounds and methods- utility
09/09/2005CA2556413A1 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
09/09/2005CA2553572A1 Immunosuppressant compounds and compositions
09/08/2005US20050197380 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
09/08/2005US20050197359 Bicyclic modulators of androgen receptor function
09/08/2005US20050197337 Aminomethylpyrimidines as allosteric enhancers of the GABAB receptors
09/08/2005US20050197333 Rifamycin analogs and uses thereof
09/08/2005US20050197330 Heterocyclic GABAA subtype selective receptor modulators
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/07/2005EP1569942A2 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569938A1 Method of making tricyclic aminocyanopyridine compounds
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569926A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569925A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569645A2 Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors
09/07/2005EP1569639A2 Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
09/07/2005EP1401839B1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene
09/07/2005EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
09/07/2005EP1347957B1 Delta 1-pyrrolines used as pesticides
09/07/2005EP1188747B1 Phenoxypropylamine compounds
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005CN1665820A Therapeutic or preventive agent for nausea/vomiting
09/07/2005CN1665806A Medicine compound
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1217918C Aminocyclohexyl ether compounds and uses thereof
09/06/2005US6939966 administering to a mammal a trans-N-[5-(2-fluorophenyl)-2-pyrimidinyl]-3-[11C]-oxospiro[5-azaisobenzofurane-1(3H), 1'-cyclohexane]-4'-carboxamide or a pharmaceutically acceptable salt for diagnostic imaging of tissues bearing neuropeptide YY5
09/06/2005US6939888 Heterocyclic amides such as 3-(2-chloro-6-methoxyphenyl)-5-isopropyl-5-methyl-4-acetoxy-3-pyrrolidine-2 -one, used as insecticides or miticides
09/06/2005US6939877 Nitrogen compounds such as 2-(4-benzo[b]thiophen-3-yl-3,6-dihydro-2H-pyridin-1-ylmethyl)-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline, used for prophylaxis of psychological disorders
09/01/2005WO2005080378A1 Fused pyridazine derivatives
09/01/2005WO2005080357A2 Oxazole derivatives, preparation and therapeutic use therof
09/01/2005WO2005080334A1 Novel heterocyclic compound
09/01/2005WO2005079792A1 Preventive or therapeutic agents for severe diabetic retinopathy
09/01/2005WO2005079791A1 Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
09/01/2005WO2005079192A2 Novel treatment
09/01/2005US20050192334 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
09/01/2005US20050192333 Spirocyclic cyclohexane compounds
09/01/2005US20050192279 Pyridazinones as antagonists of alpha4 integrins
09/01/2005US20050192277 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders
09/01/2005US20050192253 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile
09/01/2005US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation
09/01/2005US20050191643 Cyanine compounds and their application as quenching compounds
09/01/2005CA2557392A1 Preventive or therapeutic agents for severe diabetic retinopathy
09/01/2005CA2554774A1 Novel heterocyclic compound
08/2005
08/31/2005EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
08/31/2005EP1567494A1 Methods for preparing phenylalkyne derivatives
08/31/2005EP1182200B1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
08/31/2005EP1117297B1 Synthetic analogs of ecteinascidin-743
08/31/2005CN1662542A Heterocyclic compounds
08/31/2005CN1662541A Furyl compounds
08/31/2005CN1662540A 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
08/31/2005CN1662539A [1, 4]diazocino [7, 8, 1-hi]indole derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662535A Spiroindolinepiperidine derivatives
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662500A Novel azasugar derivative and drug containing the same as the active ingredient
08/31/2005CN1660851A Ramification of water-soluble camptothecin and preparation method
08/31/2005CN1660850A Method for preparing dehydrogenated cavidine, dehydrogenated apocavidine and combination
08/31/2005CN1660848A Application of alkaloid in cephalataxus fortunei esters for preventing and curing nematodiasis of plants
08/31/2005CN1216884C Dibenz [a.g] quinolizinium derivatives and salts thereof
08/31/2005CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same
08/30/2005US6936725 Photochromic compounds
08/30/2005US6936714 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
08/30/2005US6936623 Pyrano[2,3-C]imidazo[-1,2-A]pyridine derivatives for the treatment of gastrointestinal disorders
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/30/2005US6936325 Optical recording medium
08/30/2005CA2336968C Quinoline derivatives
08/25/2005WO2005077946A1 Dihydrotetrabenazines and pharmaceutical compositions containing them
08/25/2005WO2005077915A1 Pyridazinones as antagonists of a4 integrins
08/25/2005WO2005077363A1 Heterocyclic gaba-a subtype selective receptor modulators
08/25/2005WO2005023818A3 Heterobicyclic compounds as pharmaceutically active agents
08/25/2005WO2005021515A3 Inhibitors of phosphodiesterase type-iv
08/25/2005WO2004106493A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/25/2005US20050187389 Pyrrolo[2,3-d]pyrimidine derivatives; inhibitors of protein tyrosine kinase activity especially modulators of epidermal growth factor receptor; antiproliferative; anticancer; blood vessel growth, benign hyperplasia, keloid formation, psoriasis; (1-Phenylethyl)-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine
08/25/2005US20050187313 Process for aqueous milling of quinacridone pigments
08/25/2005US20050187282 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands
08/25/2005US20050187281 Spirocyclic cyclohexane derivatives
08/25/2005US20050187279 Indazole derivatives useful for the treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizure etc.
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 298